Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Warts 11 Breast Neoplasms 10 Prostatic Neoplasms 9 Keratosis, Actinic 9 Retinoblastoma 7 Uterine Cervical Dysplasia 6 Peripheral Nervous System Diseases 6 Stomatitis 4 Neoplasms 4 Uterine Cervical Neoplasms 3 Mucositis 3 Lung Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Stomach Neoplasms 2 Papillomavirus Infections 2 Pancreatic Neoplasms 2 Pain 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Melanoma 2 Keratosis 2 Deglutition Disorders 2 Carcinoma, Ductal, Breast 2 Carcinoma, Basal Cell 2 Wilms Tumor 1 Ulcer 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1

Interventions

Diathermy 20 Radiotherapy 11 Fluorouracil 4 Drug Therapy 4 Cisplatin 4 Radiation 3 Immune Checkpoint Inhibitors 3 Brachytherapy 3 tislelizumab 2 Surgical Procedures, Operative 2 Solutions 2 Immunotherapy 2 Hyperthermia, Induced 2 Hydrogen Peroxide 2 Conization 2 Capecitabine 2 spartalizumab 1 anlotinib 1 Temozolomide 1 Saline Solution 1 Radiation Dose Hypofractionation 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Oxaliplatin 1 Mitomycin 1 Ifosfamide 1 Hyperthermic Intraperitoneal Chemotherapy 1 Gemcitabine 1 Folfox protocol 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hyperthermia × Cryotherapy × Clear all

NCT04778631 2025-11-20

PERISAFE

Assistance Publique - Hôpitaux de Paris

Phase NA Completed

Hyperthermia, Agnosia, Neoplasm Metastasis, Pelvic Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡